Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$603,177,333
+$56,534,965 QoQ
Shares Held
5,320,901
-8.4% QoQ
Ownership
2.66%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#7
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. INCY ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
This page
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $603,177,333 | 5,320,901 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $546,642,368 | 5,807,930 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $663,736,766 | 6,720,024 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $671,992,963 | 7,923,511 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $558,519,081 | 8,201,455 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $407,875,032 | 6,736,169 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $241,939,291 | 3,502,813 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $178,583,889 | 2,701,723 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $161,355,768 | 2,661,758 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $88,914,045 | 1,560,717 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $74,262,548 | 1,182,713 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $72,164,088 | 1,249,162 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $58,625,307 | 941,772 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $61,171,351 | 846,428 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $57,293,782 | 713,319 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,288,077 | 694,599 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $72,613,644 | 955,820 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $67,829,048 | 854,055 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,901,258 | 461,870 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,255,434 | 294,496 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,351,299 | 241,903 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,463,646 | 42,619 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,079,563 | 81,393 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,818,219 | 131,694 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $39,597,286 | 380,853 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $157,157,290 | 2,146,078 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||